Levodopa and melanoma.
D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008545:Melanoma / Q000139:chemically induced*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced*; D009508:Nevus, Pigmented / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced*
D004295:Dihydroxyphenylalanine